LSD and Psilocybin Documents & Resources

Click here to access the investigator’s brochure (or “IB”) for psilocybin commissioned by MAPS and intended to be submitted to FDA and institutional review boards or ethics boards. The …

Newsletter: December 13, 2013

MAPS Email Newsletter: Canadian Study Officially Begins; MAPS Bulletin Now Available Online December 13, 2013 Dear friends and supporters, 2013 is ending, and the path ahead is clear. All four of our remaining …

Final Report Submitted to SwissMedic

On September 17, 2013, the Final Report for our completed Swiss study of LSD-assisted psychotherapy for anxiety associated with advanced stage illness was submitted to Swissmedic. The report contains information …

Newsletter: July 12, 2013

MAPS Email Newsletter: New Study in Colorado Treats First Subject; Zendo Project Raises Almost $10K in 10 Days July 12, 2013 Dear friends and supporters, Our study site in Charleson, South Carolina passes …